Lung cancer, often resulting from the spread of tumors originating elsewhere in the body, can potentially benefit from localized treatment options. When the number of lesions in the lungs is limited, and the condition is carefully assessed, localized therapy can serve as a valuable addition to systemic oncological treatment. This approach focuses on directly targeting the affected areas of the lungs. The text highlights a strategy for managing tumor spread to the lungs, emphasizing the importance of thorough evaluation before proceeding. Combining localized treatment with systemic therapies may offer improved outcomes for patients. This treatment could be particularly effective when dealing with a limited number of lesions within the lungs. Further research is needed to optimize and expand this treatment strategy.